503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.10%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-48.51%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
10.64%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
16.58%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
-25.73%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.02%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
-12.82%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-4.10%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-23.98%
Both companies show margin pressure. Martin Whitman would check industry conditions.
5.31%
Operating income growth 50-75% of CRWD's 9.37%. Martin Whitman would scrutinize operations.
10.96%
Similar operating margin growth to CRWD's 14.45%. Walter Schloss would investigate industry trends.
61.93%
Other expenses growth above 1.5x CRWD's 18.80%. Michael Burry would check for concerning trends.
1825.51%
Pre-tax income growth exceeding 1.5x CRWD's 20.26%. David Dodd would verify competitive advantages.
1928.92%
Pre-tax margin growth exceeding 1.5x CRWD's 24.73%. David Dodd would verify competitive advantages.
1730.30%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
1873.85%
Net income growth exceeding 1.5x CRWD's 29.52%. David Dodd would verify competitive advantages.
1979.85%
Net margin growth exceeding 1.5x CRWD's 33.47%. David Dodd would verify competitive advantages.
2300.00%
EPS growth exceeding 1.5x CRWD's 29.55%. David Dodd would verify competitive advantages.
2300.00%
Diluted EPS growth exceeding 1.5x CRWD's 29.55%. David Dodd would verify competitive advantages.
0.33%
Share count reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.
-0.07%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.